Company page

Gubra A/s

Gubra A/S is a public company listed on the Danish market under the ticker GUBRA. The company has a market capitalization of approximately 876.4 million Danish kroner. Gubra focuses on developing innovative therapies for metabolic diseases, emphasizing research and development in this field.